| ★ | Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients | ATS 2026 | Gerald Criner, MD | | 29 | Estados Unidos | |
| 5 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 69 |
| 2 | William Feldman, MD: Azithromycin Over Roflumilast in Real World COPD Data | | 182 | Estados Unidos | 74 |
| 18 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 65 |
| 3 | Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease | ATS 2026 With Gerard Criner, MD | | 113 | Estados Unidos | 71 |
| 12 | AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD | | 105 | Estados Unidos | 67 |
| 17 | Exa-Cel Approval Expands to Children as Young as 2 With Haydar Frangoul, MD | | 100 | Estados Unidos | 65 |
| 16 | Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD | | 91 | Estados Unidos | 65 |
| 4 | Diagnosing Asthma in Kids Under 5 | GINA 2025 Criteria & ICS Decisions | | 84 | Estados Unidos | 71 |
| 13 | How a Nephrologist Diagnoses and Manages Chronic Kidney Disease | | 70 | Estados Unidos | 66 |
| 8 | Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026 | | 68 | Estados Unidos | 68 |
| 11 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 67 |
| 10 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 67 |
| 19 | Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy | | 55 | Estados Unidos | 65 |
| 6 | SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026 | | 48 | Estados Unidos | 69 |
| 7 | Why Dermatologists Must Rethink Antibiotic Prescribing | Douglas DiRuggiero | | 46 | Estados Unidos | 68 |
| 9 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 67 |
| 20 | Abdominal Pain and Bloating: Recognizing HAE, MCAS, and Eosinophilic GI Disorders | Brian Lacy, MD | | 20 | Estados Unidos | 65 |
| 1 | How ABCG2 Inhibition Could Change EPP Disease Management | | 17 | Estados Unidos | 74 |
| 15 | Early Introduction & Rescue Refeeding: Rethinking Pediatric Food Allergy | Marcus Shaker, MD | | 17 | Estados Unidos | 66 |
| 14 | How Should Clinicians Address the Link Between Atopic Dermatitis and Allergy? With Jay Lieberman, MD | | 13 | Estados Unidos | 66 |